v3.22.4
Goodwill and Intangible Assets
 3 Months Ended
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets Goodwill and Intangible Assets
The following table sets forth goodwill by segment:
Wet
Shave		Sun and Skin
Care		Feminine
Care		Total
Gross balance at October 1, 2022$1,133.5 $354.5 $205.2 $1,693.2 
Accumulated goodwill impairment(369.0)(2.0)— (371.0)
Net balance at October 1, 2022$764.5 $352.5 $205.2 $1,322.2 
Changes in the three months ended December 31, 2022
Cumulative translation adjustment8.0 1.2 0.9 10.1 
Gross balance at December 31, 2022$1,141.5 $355.7 $206.1 $1,703.3 
Accumulated goodwill impairment(369.0)(2.0)— (371.0)
Net balance at December 31, 2022$772.5 $353.7 $206.1 $1,332.3 
The following table sets forth intangible assets by class:
December 31, 2022September 30, 2022
Carrying
Amount		Accumulated
Amortization		Net
Carrying
Amount		Accumulated
Amortization		Net
Indefinite lived
Trade names and brands$593.9 $— $593.9 $587.1 $— $587.1 
Amortizable
Trade names and brands$339.6 $76.4 $263.2 $339.4 $72.2 $267.2 
Technology and patents78.4 75.7 2.7 77.8 75.0 2.8 
Customer related and other269.7 132.7 137.0 267.1 127.6 139.5 
Total amortizable intangible assets$687.7 $284.8 $402.9 $684.3 $274.8 $409.5 
Amortization expense was $7.7 and $6.1 for the three months ended December 31, 2022 and 2021, respectively. Estimated amortization expense for amortizable intangible assets for the remainder of fiscal 2023 and for fiscal 2024, 2025, 2026, 2027 and 2028 is $23.0, $30.7, $30.6, $30.4, $30.4 and $30.3, respectively, and $227.5 thereafter.
Goodwill and intangible assets deemed to have an indefinite life are not amortized but are instead reviewed annually for impairment of value or when indicators of a potential impairment are present. The Company’s annual impairment testing date is July 1. An interim impairment analysis may indicate that carrying amounts of goodwill and other intangible assets require adjustment or that remaining useful lives should be revised. The Company determined there was no triggering event requiring an interim impairment analysis during the three months ended December 31, 2022.